Skip to main content
. 2020 Jul 22;12(8):2008. doi: 10.3390/cancers12082008
CEL Celecoxib
CDH1 E-cadherin (Epithelial cadherin)
CoCl2 Cobalt chloride
COX-2 Cyclooxygenase-2
CPEB2 Cytoplasmic polyadenylation element-binding protein 2
ELISA Enzyme-linked immunosorbent assay
EMT Epithelial-to-mesenchymal transition
EP4 Prostaglandin E2 receptor 4
ER Estrogen receptor
HER2 Human epidermal growth factor receptor 2
HIF-1α Hypoxia-inducible factor 1-alpha
miRNA/miR MicroRNA
mRNA Messenger RNA
NFκB Nuclear Factor Kappa-light-chain-enhancer of activated B cells
NFκB1 Nuclear factor NF-kappa-B p105 subunit
NR2C2 Testicular receptor 4
ONO ONO-AE3-208
PGE2 Prostaglandin E₂
PHD Prolyl hydroxylase domain
PI3K Phosphoinositide 3-kinases
PR Progesterone receptor
Pri-miRNA Primary miRNA
PTEN Phosphatase and tensin homolog
ROS Reactive oxygen species
SALL2 Sal-like protein 2
SALL4 Sal-like protein 4
SLC Stem-like cell
SNAIL Zinc finger protein SNAI1
SO Superoxide
TCGA The Cancer Genome Atlas
TWIST1 TWIST1-related protein 1
TXNRD1 Thioredoxin reductase 1
VEGF Vascular endothelial growth factor
VEGFA Vascular endothelial growth factor A
VHL Von Hippel–Lindau tumor suppressor
VIM Vimentin
WM Wortmannin
ZNF207 Zinc finger protein 207